RHOA and lymphoma: In these various murine models, RhoA-G17V overexpression in T cells promoted TFH proliferation/expansion (43, 44) and the concomitant expression in the setting of hematopoietic TET2 deficiency led to the development of TFH lymphomas with varying penetrance (43–45).